Press releases and Presentations
CNSide™ News
Stay apprised of late-breaking data and information about the CNSide™ CSF assay and FORESEE clinical trial.
Press Releases
Presentations
November 24, 2024 // SNO Annual Meeting
CSF Tumor Cell (CSF-TC) Detection, Quantification and Biomarker assessment Helps in Clinical Management of Breast Cancer and Non-Small Cell Lung Cancer Patients Having Leptomeningeal Disease (FORESEE Study, NCT-5414123)
November 22, 2024 // SNO Annual Meeting
The Oncogenic Flip in Patients with Leptomeningeal Metastatic Disease (LMD): Longitudinal Detection in Cerebrospinal Fluid Tumor Cells (CSF-TCs) Reveals Implications for Differential Treatment of the LMD Tumor
August 10, 2024 // SNO ASCO CNS Metastases Conference
CSF Tumor Cell (CSF-TC) Detection, Quantification
and Biomarker assessment helps in clinical
management of breast cancer and Non-Small Cell
Lung cancer patients having Leptomeningeal
Disease (FORESEE Study, NCT05414123)
August 8, 2024 // SNO ASCO CNS Metastases Conference
Update on CSF Diagnostics in LMD:
Because all that enhances ISN’T cancer